TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders

NCT07377032 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

GRIN-related Disorders
GRIN1
GRIN2A
GRIN2B
GRIN2D
Epilepsy
Neurodevelopmental Disorder (Diagnosis)

Interventions

DIETARY_SUPPLEMENT: L-serine
OTHER: Maltodextrin (Placebo)

Sponsor

Meyer Children's Hospital IRCCS